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 ABBREVIATION 
 
OSMF : Oral Submucous Fibrosis 
ALA  : Alpha Lipoic Acid 
NON-ALA : Non Alpha Lipoic Acid 
DCP  : Differential Count Polymorpho Nuclear Leukocytes 
DCL  : Lymphocytes 
DCE  : Eosinophils 
DCM  : Monocytes 
HB  : Hemoglobin 
BL  : Betal Leaf 
BN  : Betal Nut 
1 
 
1. INTRODUCTION 
  Oral sub mucous fibrosis is a precancerous lesion, predominant 
condition seen in South Asian ethnic group ,more in India .No age or sex 
predilection has been found. OSMF is primarily a cell mediated immune 
reaction to areca nut chewing and betel quid. It is prevalent in people belonging 
to poor socioeconomic status associated with nutritional deficiency. 
In 1953 S.G.Joshi termed this condition as Oral sub mucous fibrosis. 
And latter it was described by Pindborg and Sirsat in (1966).1 
In simple words Oral sub mucous fibrosis is a chronic progressive 
crippling fibrotic but preventable disease. 
Manifestations are dryness and burning sensation in the mouth, 
blanching of oral mucosa and reduced mobility of tongue. 
It is a chronic pre-cancerous condition leading to juxtaepithelial fibrosis 
mainly at Retro molar trigone and Soft palate. 
Young people are attracted by the media publicity of areca nut 
preparations thereby getting addicted to the same. There are 5 million young 
Indians affected from this crippling disease. 
Most important aspect of the treatment is cessation of the habits.  
Intralesional steroids are commonly used, but the dose and duration of the 
treatment have not been standardized so far. Other treatments include 
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placentrex, hyaluronidase, collagenase, elastase and oral zinc and 
pentoxiphylline. 
Five of the study population including two school students are below the 
age of 20, since there is no restriction for sale of areca products in public 
places, these age groups are more vulnerable for addiction. 
There must be careful observation and long term follow up,  
Patients are instructed that at any time it may recur and may worsen 
even to malignancy. 
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2. JUSTIFICATION 
 
Young patients are chewing processed areca nut due to a change in 
lifestyle leading to adoption of the habit at a younger age. 
In this study five are less than 20 years of age, among them two are 
school going age. Less cost, easy availability and sale in prohibited areas like 
public places, near schools and colleges makes young people vulnerable for 
addiction. 
OSMF causes restriction in mouth opening, reduction in food intake, 
patient become malnourished and anaemic. 
School students and College students are also getting addicted to these 
chewing habits even after knowing the seriousness of the addictive quality and 
the danger of oral cancers.  
In this study all the patients were strictly advised to stop the oral abusive 
habit at the beginning itself. And there must be a careful observation and 
follow up for each and every case for at least one to two years. 
  All the available treatment for OSMF is only a minimal improvement 
and symptomatic relief that is why this study was conducted to evaluate the 
efficacy of oral Antioxidant therapy by using Alpha lipoic acid.                                                                        
4 
 
In a study to evaluate the effectiveness of Alpha lipoic acid (ALA) by 
randomized double-blind placebo-controlled trial there were significant 
improvements in the symptoms notably burning sensation of mouth.2         
Areca nut and tobacco are the precipitating factors.  Preventive 
measures and habit restriction should be followed in all clinically suspected 
cases to retard the progression of disease. In South-East Asian countries the 
habits of consuming tobacco, betel nut are more in India.  The reason for this is 
majority of Indian population depend on agriculture for their living and 
income.  After working in fields, they take these substances as light food, till 
they reach home.   
 It is easily available in their work places.  When people are asked, they 
say there is a feeling of satiety in between meals when they have this.  Some 
others have a sense of well-being.  One other pathetic condition is that they 
take it some five to ten times in a day.  In villages young people and children in 
their home also start taking this automatically since they are constantly exposed 
to their parents and grandparents who are habitual chewers. 
When the above scenario is going on one side, the people in town and 
cities are exposed in a different way.  They have a different attitude towards 
chewing.  Some people take it for bad breath.   
 In still more developed area, the estimation is like that of a fashion 
among youngsters to chew this.  They get these substances readily from shops 
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nearby.  Even though there is prohibition to sell nearby Educational 
institutions, it is not being followed strictly. 
More over Thiruvaiyaru taluk in Thanjavur district is well known for 
betel plant, seeval (betel nut product). And tobacco factories are there in 
Thanjavur. People here have the habit of chewing when they get together for 
functions. 
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3. AIMS AND OBJECTIVES 
  
1. To study the clinical features of the patients with Oral submucous 
fibrosis attending the outpatient department of Otorhinolaryngology 
Thanjavur Medical College Hospital, Thanjavur. 
 
2. To measure the Efficacy of Alpha lipoic acid in the management of 
Oral submucous fibrosis. 
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4. REVIEW OF LITERATURE 
I.  ANATOMY  
II. AETIOLOGY 
III. EPIDEMIOLOGY 
IV. PATHOGENESIS 
V.PATHOLOGY 
VI. CLASSIFICATION AND STAGING 
VII. COMPLICATION 
VIII. TREATMENT PRINCIPLES AT VARIOUS LEVELS 
IX.ARECA NUT AND ITS ADVERSE EFFECT 
X. ALPHA LIPOIC ACID (ALA) 
XI.OTHER PREMALIGNANT AND MALIGNANT LESIONS OF ORAL 
CAVITY 
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I.SURGICAL ANATOMY OF ORAL CAVITY AND 
OROPHARYNX. 
ORAL CAVITY3 
   Outer part is called vestibule and the inner part is called oral cavity 
proper.    
LIPS 
  Upper and lower lips are lined by skin in outer part, mucous membrane 
inside. It consists of skin, superficial fascia, orbicularis oris and submucosa, 
CHEEKS 
Present on either side of oral cavity 
It Consists of skin, fascia,buccinators ,submucosa and mucous membrane.     
ORAL CAVITY PROPER 
BOUNDARIES 
    Roof of the oral cavity is formed by palate, 
Floor is formed by Tongue 
Posteriorly it is opening into pharynx 
Anteriorly it is bound by teeth and gums 
 
9 
 
GUMS: Tissue surrounding the alveolar process of the jaw, it contains fibrous 
tissue. 
It has two parts 
1. Loosely encircling neck of tooth a collar, 
2. Firmly attached to alveolus. 
 
HARD PALATE: Separates nose and oral cavity, formed by palatine process of 
maxilla anteriorly and palatine bone posteriorly 
SOFT PALATE: it is a muscular structure hanging from posterior part of hard 
palate, separates nasopharynx and oropharynx. 
 
ANATOMY OF RETROMOLAR TRIGONE 
It is a triangular area of mucosa overlying ascending ramus of the 
mandible .Apex is formed by maxillary tuberosity and the base is formed by 
last molar tooth. 
Laterally it continues as gingivobuccal sulcus and medially as 
gingivolingual sulcus.  
Since mucosa adhere closely to the mandible, if any malignancy occurs 
in this area will infiltrate easily in to the mandible and inferior alveolar nerve. 
It is divided in to the following components,  
10 
 
 
OROPHARYNX  
ANTERIOR WALL 
It is formed by posterior third of tongue posterior to foramen caecum 
and vallecula. 
LATERAL WALL 
It continuous as palatoglossus muscle, palatopharyngeus muscle and 
palatine tonsil. 
ROOF 
Formed by soft palate. 
POSTERIOR WALL 
 Anterior to second and third cervical vertebra. 
 
The lymphatic drainage of Oropharynx is mainly in to 
 1. Jugulodigastric nodes,  
2. Retropharyngeal nodes and 
3. Parapharyngeal nodes.                                                                         
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NORMAL HISTOLOGY OF ORAL MUCOSA4 
Mucous membrane of the oral cavity consists of stratified squamous 
epithelium and the connective tissue supporting mucosa is called lamina 
propria. 
In the oral cavity, there is no clear distinction between lamina propria 
and sub mucosa.  
The oral mucosa varies from site to site within the oral cavity, but the 
epithelium is stratified squamous at all the sites.  This epithelium is partially 
keratinized on gingiva and hard palate and on tongue, non-keratinized in other 
areas of oral cavity.  Oral epithelial tissue continuously undergoes reproduction 
and new cells replace the dead cells.5 
 
II. EPIDEMIOLOGY 
Incidence: sudhakar vaidya  has stated in  world article in ear, Nose 
and Throat as6 
 Incidence - 4/1,000 adults in rural India  
 5 million young Indians are affected due to increased use of gutkha and pan 
masala7  
        The disease is predominantly seen in Asian countries, prevalence being 
more in India.  
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   OSMF is also reported in South Asian origin living outside, but very 
rare in White population. 
III.AETIOLOGY 
 1) Areca nut is otherwise called areca catechu; the seed is called areca 
nut. It grows commonly in tropical part of pacific, Asia and parts of east 
Africa.8 
2) Tobacco chewing: it is chewed alone or it is combined with betel nut, 
betel leaf and lime.  
3) Pan Masala: Areca nut is the main constituent of all 'pan masala’ 
that 
may or may not contain tobacco.9 
4) Gutkha: It is prepared from betel nut and tobacco, it is sweet in taste. 
gutkha and pan masala are on greatest use in recent days especially among 
youth . 
5) Taking Spicy food  
6) Nutritional deficiencies: in the form of anaemia, chronic iron 
deficiency and vitamin B deficiency synergize progression of the disease.  
According to the case report, British Dental Journal 191, 130 (2001) 
.Nutritional deficiencies, Iron, B-12 considered as predisposing factor for 
OSMF. 
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7) Low Socio Economical Status: OSMF is prevalent in people of Low 
Socio Economical Status.           
8) Immunological disorders: Raised ESR and globulin levels are 
indicative of immunological disorders. Serum immunoglobulin levels of IgA, 
IgG and IgM are raised significantly in OSMF. These raised levels suggest an 
antigenic stimulus in the absence of any infection. Circulating autoantibodies 
are also present in some cases of OSMF. 10 
9) Genetic disposition: 
HLA 10, DR 3and DR 7 has been noted in OSMF 11 
10) Poor oral hygiene  
11) Streptococcal infection 
12) Localised collagen disease 
13) OSMF is also seen among few non -Areca nut chewers. 
Causes  
1. Immunological process and 
2. Genetic components 
In those patients increased level of pro-inflammatory cytokines are found. 
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IV. PATHOGENESIS:                                                                           
OSMF results from increased production of collagen by fibroblasts. In 
addition to this there is decreased breakdown leading to accumulation of 
excessive amount of collagen. 
 
I. INCREASED SYNTHESIS OF COLLAGEN12 
Arecoline and Arecadine are present in the areca nut stimulate 
fibroblast. Some Other growth factors also stimulate fibroblast. The only 
cytokine with anti-collagen effect is interferon, which is decreased in OSMF 
 
II. DECREASED BREAKDOWN 
  Chewing areca nut increases copper level that stimulates fibrogenesis 
Tannin in betel nut stabilise collagen by cross linking effect.Furthur type III 
collagen is converted to type I collagen which is relatively resistant to 
degradation. 
 
Both tannin and copper makes collagen highly resistant remodelling and 
phagocytosis. 
 
Areca Nut   
 
1. Alkaloids       Fibrosis          increase collagen synthesis. 
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2. Tannins & catechins stabilize cross link between collagen & 
elastin molecules. 
 
      
3. Copper increases collagen formation, decreases the phagocytosis. 
 
 
4. Trauma during chewing      Inflammation       growth factors. 
 
 
Tobacco gives polycyclic aromatic hydrocarbon.  It is changed into a 
carcinogen with the help of Aryl hydro carbon hydroxylase. 
Flavanoids and tannins resist degradation caused by collagenase. 
 
Arecolin      Fibroblast proliferation  Collagen synthesis13 
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CLINICAL FINDINGS  
1. Constant dryness of mouth 
2. Burning sensation of mouth 
3. Intolerance to chillies and spicy food  
4. Repeated vesicular eruption, 
5. Ulceration,  
6. Difficulty in opening the mouth and 
7. Difficulty in protruding tongue. 
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Changes of OSMF are most marked over soft palate, faucial pillars and 
buccal mucosa. 
In the initial stage there will be redness and formation of vesicles, which 
will rupture and form superficial ulceration, 
In the later stage there will be blanching of mucosa after that fibrosis 
will develop, fibrotic bands will be seen in the affected areas. It looks like 
‘marble’  
Fibrosis and scaring extends in to the underlying muscles leading to 
restriction of mouth opening and further restriction by involving soft palate and 
tongue. 
Trismus is gradually progressive and patient may not be able to open his 
mouth and put his finger or brush to clean his teeth and also there will be 
restriction to the tongue movement that prevents self cleaning action of the 
tongue over the teeth, thereby oral hygiene is badly affected and teeth become 
caries. 
As the disease progresses, the examination of oral cavity will also 
become difficult to rule out other pre-malignant lesion or malignancy. 
Expression of heat shock protein -70 in OSMF and oral cancers. It is a 
useful biomarker.  This heat shock protein is synthesised during stress 
situation. 
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Thus stress plays important role in predispose OSMF, oral squamous 
cell carcinoma, most of the studies reveal there is increase in the incidence of 
OSMF.   
Increase in prevalence among young generation threatening oral cancers 
in the future.  In early stage it involves only the buccal mucosa at retromolar 
trigone. 
In advanced cases it involves soft palate, uvula may get atrophied, 
tongue and lips.  
There will be restriction of tongue movement and self cleaning action of 
the tongue is affected, oral hygiene is also affected streptococcal infection 
causing more and more damage to the oral mucosa. 
OSMF considered as an analogue of Plummer- Vinson syndrome. 
Oral candidiasis also will promote the malignant transformation by 
nitrosamines. 
Rate of malignant transformation of OSMF is 7-13% as per the previous 
studies.  Incidence of squamous cell carcinoma is higher in OSMF. 
High frequency of epithelial dysplasia and higher prevalence of 
Leukoplakia in OSMF noted. According to the five criteria’s given by pindborg 
for diagnosing precancerous condition. 
Ulceration and burning sensation of mouth leads to less consumption of 
food leading to anaemia, it is a vicious cycle.  
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OSMF is an inflammatory disorder.  Biopsy taken from the buccal 
mucosa is showing cyclo-oxygenase expression.  It is mediated by 
prostaglandins.  And inflammatory cells are seen in initial stage and later it will 
disappear. 
Even though OSMF is being diagnosed clinically, Biopsy is mandatory 
to confirm the diagnosis and to rule out dysplasia and malignancy. 
Muscle stretching exercises should not be more violent, this must be 
gentle, so that it may not give adverse effect on already affected muscles. 
Heavy force used to crush the hard nut in betel nut chewers will produce 
muscle damage. 
 
VI. CLASSIFICATION AND STAGING                                              
Oral submucous fibrosis is clinically divided into 3 stages (Pindborg 
J.J.)14 
      Stage 1: Stomatitis 
      Stage 2: Fibrosis 
a- Early lesions, blanching of the oral mucosa 
b- Older lesions, vertical and circular palpable fibrous bands in 
and around the mouth or lips, resulting in a mottled, marble-like 
appearance of the buccal mucosa 
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       Stage 3: Sequelae of oral submucous fibrosis 
                     A. Leukoplakia 
B. Speech and hearing defects 
                 
HISTOPATHOLOGICAL STAGING OF OSMF15 
VERY EARLY STAGE (GRADE I) 
            Finely fibrillar collagen, dispersed with marked oedema, fibroblastic 
response is strong, blood vessels are sometimes normal, but more often they 
are dilated and congested, inflammatory cells, mainly polymorphonuclear 
leukocytes with an occasional eosinophil are present. 
EARLY STAGE (GRADE II) 
Juxta epithelial area shows early hyalinization, plump young fibroblasts 
are present in moderate numbers. Blood vessels are dilated and congested, 
inflammatory cells are mostly mononuclear lymphocytes, eosinophils and 
occasional plasma cell 
MODERATELY ADVANCED STAGE (GRADE III) 
Collagen is moderately hyalinised. Fibroblastic response is less marked, 
cells present being mostly adult fibrocytes, blood vessels are normal or 
constricted, inflammatory exudates consist of lymphocytes and plasma cells, 
although  an occasional eosinophil is seen. 
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ADVANCED STAGE (GRADE IV) 
Collagen is completely hyalinised.Hyalinized areas are devoid of 
fibroblasts. Blood vessels are completely obliterated or narrowed. The 
inflammatory cells are lymphocytes and plasma cells.  
 
VII.COMPLICATION 
1. Trismus leads to poor food intake causing malnourishment and anaemia 
which will further worsen the subepithelial fibrosis and trismus. 
2.  Nutritional deficiency will synergize OSMF.16 
3. Unable to move the tongue, so failure to clean the oral cavity after 
taking food. 
4. Ankyloglossia. 
5. Speech and Hearing problem. 
6. 3 to 10% of people having OSMF are at risk of malignant 
transformation. 
 
VIII. TREATMENT PRINCIPLES AT VARIOUS LEVELS  
A. NON PHARMACOLOGICAL TREATMENT 
1. To stop chewing areca nut and tobacco 
 2. Avoid taking spicy foods, including chillies, fast food 
3. Supplementing diet rich in vitamins and minerals 
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4. Maintaining Proper oral hygiene 
5. Forgoing alcohol 
6. Avoid taking hot fluids like tea, coffee  
7. Encouraging jaw opening exercises by using dental screw or wooden 
pamparam (in Tamil) 
 
B. MEDICAL LINE OF MANAGEMENT 
1. Placental extract,  
2. Trypsin,  
3. Collagenase,  
4. Hyaluronidase   
5. Elastase  
6. Intralesional Interferon-γ.17 
7. Triamcinolone 
 8. Oral zinc  
9. Oral pentoxiphylline. 
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10. Fibrinolysin and 
11. Gold 
12. Submucosal injections of hydrocortisone 100 mg once in a week for 12 
weeks.18 
13. Vitamins A, B-complex, c and iron. 
Iron is needed for angiogenesis, Cytochrome oxidase in  iron required 
for normal epithelial maturation.In iron deficiency anamia ,there will be 
atrophy of epithelium and  decrease in vascularity ,which will  lead on to 
dryness of mouth. 
14. Oral nutritional supplement of Lycophene 16 mg daily .the effect can be 
enhanced by intraletional Betamethasone”19 
15. Stem Cell Therapy 20 
16. Chymotrypsin 
 
Hyaluronidase and steroid used in combination gives better long term 
result than either of them used alone.  
C.SURGICAL TREATMENT  
Aim of the surgical procedure:  To get adequate mouth opening. 
 Anaesthesia                             : GA (General Anaesthesia) Naso-tracheal 
intubation 
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Maxillary, mandibular occlusal splint used mouth gag applied to obtain splint 
to split distance of 35mm 
1. Surgical excision of fibrotic band with submucosal placement of fresh 
human placental graft21 
2. bilateral tongue flaps 
3. Nasolabial flap 
4. Island palatal mucoperiosteal flaps 
5. bilateral radial forearm free flap 
6. Surgical excision and buccal fat pad graft22 
7. Superficial temporal fascia flap and split skin graft 
8. Coronoidectomy and temporal muscle myotomy 
9. KTP-532 laser release procedure 23 
10.  Nowadays Co2 laser is preferred 
                    Advantages 
It cuts precisely and 
 Stop bleeding  
Wound healing without contracture in laser 
excision 
To avoid recurrence of trismus after surgery, inter positional graft are 
used.  Removal of Fibrotic band by surgery may result in further scar 
formation. 
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Post Operative care 
• Ryle’s tube feeding 
• Oral hygiene 
• Mouth opening exercise – Heister’s mouth gag  
• Normal saline mouth wash / irrigation. 
 
D.PHYSIOTHERAPY 
1. Heat therapy- Hot rinse by Luke worm water 
2. Microwave therapy -Selective heating at subepithelial connective 
tissue 24 
E. Nutritional support 
1. High protein diet, Iron, Vitamin A, B complex, C, D and E, iron, 
Copper, calcium, Zinc, Magnesium, Selenium, Protein diet and milk.25 
 
IX.ARECA NUT AND ITS ADVERSE EFFECT 
Areca nut: it is unhusked whole fruit of the areca nut tree. 
Betel nut: it is inner kernel (seed), after removing husk. 
Commercially prepared pan masala, Gutkha have been marketed widely for the 
past 20 years. 26 
Pan Masala, Gutkha Industries have risen very shortly and quickly.  
Areca in any form is risk for health. 
26 
 
 
There are two varieties in betel nut preparations. 
They are 
1. Plain variety 
2. Sweet variety 
 
 Plain variety (astringent) 
 Cardamom and tobacco are added. 
Sweet variety 
 It consists of Cardamom, cloves, coconut, sugar crystals, camphor, 
amber, nutmeg and colouring agents. 
Supari 
 Roasted and flavoured pieces of areca nut 
 
People of north east part of India using ‘TAMOL’ the fermented areca 
nut.  In our country tobacco is added in the quid.27 
Since areca nut is chewed wrapped with betel leaf, it is called betel nut. 
It has central nervous system stimulation and taken at the end of meal for 
digestion and breath of mint. 
Since the areca products are inadequately labelled, bearing no health 
warnings in the labels and no restriction on sale to students and children makes 
people vulnerable to these chewing habits. 
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 Sliced and chewed betel nut will directly irritates the mucosa and sharp 
edges of the betel nut will cause more damage and force used to crush the hard 
nuts. 
Betel quid chewing is more common in women than males.  
It has got social acceptance in our society.  
It consists of betel nut, betel leaf and slaked lime. 
Betel nut is one of the commonly used psychoactive substances among 
rural as well as urban population our country. 
Copper in areca nut 
1% Bordeaux sprays is used to prevent fungal infection to areca plant.  
This solution consists of copper sulphate. Incorporation of copper into the areca 
nut is by spraying the Bordeaux mixture on areca plantations.   
Copper level increase in salvia 15-30 nuts of chewing areca nut, local 
absorption of copper by transmucosal transport through epithelial cells, as non-
enzyme dependent diffusion (Metallothionein protein), leading onto collagen 
formation and  increase in lysyl oxidase activity, it further  leads to cross 
linking of collagen and elastin molecules, thereby reduces the action of 
collagenase and  prevent breaking of collagen. 
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Copper content 
CONSTITUENTS COPPER 
Red areca 18.3 ppm 
White areca 14.9 ppm 
Betel leaf 18.5 ppm 
Gutkha 13.2 ppm 
Flavoured areca 12.2 ppm 
Tobacco 6.3 ppm 
 
Betel leaf consists of highest amount of copper 
Alkaloids in betel nuts are irritating the mucosal surface, and damage 
the epithelium and causing juxtaepithelial fibrosis and thereby leading onto 
trismus. 
The compositions of various areca nut preparations are different from 
one another according to the place where they are prepared. 
Alkaloid content can be reduced in the betel nut by soaking and boiling 
processes. 
Areca nut was used in Gujarat state in India mostly in the form of 
mawa, a mixture of tobacco, lime and areca nut. And 10.9% of mawa users had 
OSMF. The study conducted in Gujarat state in India says that   “increased use 
of areca nut products in younger age groups leads OSMF and increase the 
incidence of oral cancer in the future.”        
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M.K. Gupta*, Shubhangi Mhaske, Raju Ragavendra have recently 
suggested that “there is dual action of areca nut. It issuggested that arecoline 
not only stimulates fibroblastic proliferation and collagen synthesis but also 
decreases it’s breakdown. This suggests that arecoline is the active metabolite 
in fibroblast stimulation”. 28 
Areca nut preparation and Betel quid chewing are practised 
predominantly in South Asia and in India,   the risk of oral cancer increased 
with the duration and frequency of the habit.29          
           
ADVERSE EFFECTS FROM CHEWING ARECA PRODUCTS 
A) The areca nut contains  
1. Tannins 
2. Arecatannins 
3. Gallic acid     
           4. Arecolins  
   5. Arecaidines and 
  6. Guvacine  
  Last three are alkaloids and all are having vasoconstriction properties.  
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D) Betel nut chewing will produce exacerbation of bronchial asthma and 
elevation of blood pressure30 
  E) There may be chances of malignancy in internal organs 31 
 F) There is a risk of getting type 2 diabetes mellitus.31 
G) Areca nut chewing in psychiatric patients further worsens the condition32                                                                                     
H) During pregnancy significant increase in the adverse outcomes for the baby. 
Incidences of lower birth weight, pre term were found to be high.  There is 
an 11 fold increased risk of malignant transformation in persons who chew 
betel quid.  This chewing habit has become an addiction.33                                                                                    
 
As Gupta prakash explains “While chewing they used to take a few slices 
of the areca nut wrapped in a fresh betel leaf along with lime (not the citrus 
fruit named lime), some people may add clove, cardamom and catechu”.34  
Arecolins will interfere with the ECM – Extra Cellular matrix molecules 
commonly collagen.  Phagocytic activity caused by fibroblast is prevented.  
  There will be increased secretion of inflammatory cytokines, Growth 
factors and decreased production of anti-fibrotic cytokines. 
Important feature of OSMF is Juxta epithelial fibrosis affects most of 
the parts of the oral cavity, pharynx, upper 1/3 of oesophagus including 
pyriform sinus. Thereby leading to dysphagia and progressive trisums. 
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Among all the alkaloids (Arecoline, arecaidine, Guvacine and 
Guavacoline) Arecoline is the important agent. 
It has got parasympathetic activity which gives Euphoria and 
counteracts fatigue.   
Chronic exposure to those irritants will lead on to malignant 
transformation.  Chewers are taking copper 5mg/day in areca nut. 
Tannic acid, Arecolins in the betel nut and Calcium hydroxide 
(Ca(OH)2) added as slaked lime are affecting the vascularity or the buccal 
mucosa. Tannin will synergize this action. 35 
In areca nut chewers’ Excessive activity of muscles due to repeated 
chewing and using heavy force to crush the hard nut.36 
There is already reduced blood supply.  Increased muscle activity and 
reduced blood supply causing muscle degeneration and fibrosis. 
The fibrosis and less vascularity with altered cytokine activity make the 
environment for carcinogenic tobacco and area nut to act upon the epithelial 
surface.  These carcinogens will act for a longer duration separately. 
 Atrophic epithelium leads to intercellular oedema then epithelial atypia 
and letter it will turn into epithelial hyperplasia.In this stage malignant 
transformation may take place at any time. 
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OSMF will not regress on its own or after stopping chewing habits. 
Once the disease sets in, it persists or progress. 
And it involves adjacent areas like soft palate, tongue and even down up 
to pyriform fossa.  
 
X.ALPHA LIPOIC ACID (ALA) 
Alpha Lipoic Acid (ALA) is an anti oxidant found in fruits and 
vegetables like Green Pepper, Tomatoes, Grapefruit and Lemon/Limes25 
ALA fights with free radicals .free radical damages cells tissues and 
organs in our bodies ALA is both water and fat soluble 
Green pepper is high in alpha lipoic acids, according to the George 
Mateljan Foundation. In addition, green peppers are good sources of vitamin C, 
thiamine, vitamin B6, beta carotene and folic acid.25 
Alpha lipoic acids have been found in tomatoes and are commonly 
synthesized for use in skin creams. Tomatoes also contain the powerful 
antioxidant lycopene. Lycopene protects from certain cancers as well as 
protecting the heart.26                                                               
Lemons and limes contain alpha lipoic acids and can be cooked or 
ingested raw. Lemon and limes contain limonoids, a compound that has been 
shown to help fight cancers. 
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The alpha lipoic acids found in grapefruit Grapefruit's high antioxidant 
activity can be ingested in the form of fresh juice. 27 
ALA enhances the activities of vitamin C, E and Co-enzyme Q and it 
raises the level of Glutathione and thereby prevent the cell injury caused by 
reactive free radicals. 
Lycophene 
• Is an anti-oxidant from plants 
• A red carotenoid source pigment 
• Extracted from tomato. 
• Considered to reduce risk of atherosclerosis, Myocardial Infarction and 
other cancers. 
• Tetraterpenes – carotenoid. 
• C40 yellow or orange red carotenoid pigment. 
• Around 500 such compounds have been identified. 
• They are formed by tail to tail union of 2 molecules of C20 
geranylgeranyl diphosphate to give an acyclic intermediate with a cis – 
configuration of central double bond. 
• By changing the above configuration to desaturating isophrenoid chain 
Lycopene. 
 
Interferon - Gamma 
It is Anti- Fibrotic cytokine.   
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It will alter the collagen synthesis  
It is used intralesionally 
 
Placental extract 
Placental extract is having growth factors and Anti inflammatory agents. 
Anti inflammatory and anti-platelet activities are seen . 
There are two important reasons for using placental grafts in OSMF  
1.  hormonal effect, 
2. mehanical effect.  
Hormonal: Biogenic stimulant effect is because the placenta is a homograft, 
immunologically competent and rich in steroids, proteins, chorionic 
gonadotrophins, estrogens and progesterone. 
The grafts are easily mouldable and undergo total absorption only after 
prolonged periods, thus mechanically preventing fibrosis. 
It is reported in studies, 
Hyaluronidase acts upon the collagen and reduce the density of the 
intercellular cement substances, and it breaks down hyaluronic acid and 
prevents collagen formation. 
As stated by Rajendran R et al.39High protein diet,Iodinated salt,Vitamins 
and Minerals are very essential in the management of OSMF. 
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XI.OTHER PREMALIGNANT AND MALIGNANT LESIONS OF 
ORAL CAVITY40 
PREMALIGNANT LESIONS OF ORAL CAVITY 
Following are the premalignant condition of Epithelial lining of oral mucosa 
which may turn to become squamous cell carcinoma. 
1. Dysplasia. 
2. Leukoplakia 
3. Proliferative verrucous leukoplakia 
4. Erythroplakia 
5. Nicotine Stomatitis 
6. Actinic Cheilitis 
7. Smokeless tobacco keratosis 
8. Lichen planus and 
9. Melanosis and mucosal hyper pigmentation 
 
1. Dysplasia 
There will be alteration in Cell as  dark staining nuclei and Nuclear, 
Cytoplasmic ratio altered 
Loss of Mitotic activity, 
Cellular maturation from basal cells to flattened superficial cells. 
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Carcinoma insitu Full or almost full thickness architectural 
abnormalities in viable cellular layers along with cytological atypia.  
 
2. Leukoplakia 
White patch or plaque that cannot be characterized clinically or 
pathologically as any other disease and is not associated with any physical or 
chemical causative agent except the use of tobacco. 
- middle age and older population 
- after 40 years 
floor of month is the  Most Common  site in smokers.  
WHO defined leukoplakia as a clinical white patch that cannot be 
characterized clinically or pathologically as any other disease.  It is a clinical 
definition and does not take pathology into consideration.  
 Other white lesions of oral mucosa, 1. lichen planus,  
                                                2.discoid lupus erythematosus and 
                                                3.white spongy nevus . 
 Aetiology:  smoking 
 tobacco chewing,  
alcohol  
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 Ill-fitting dentures and 
 cheek bites.   
It may also be associated with submucous fibrosis, hyperplastic candidiasis or 
Plummer-Vinson syndrome. 
 
 Sites involved. Buccal mucosa  
 oral commissures  
    floor of mouth,  
tongue,  
gingivobuccal sulcus and  
mucosal surface of lip.   
 
Buccal mucosa is the most common site in India. 
 
 Age and Sex. Mostly, it is seen in the fourth decade, males are affected 
two to three times more often. 
Clinical types 
a) Homogenous -  It is less often associated with malignancy. 
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b) Nodular variety -presents as white patches or nodules on 
erythematous base; 
c) Erosive (erythroleukoplakia) it  has erosions and fissures.and  
higher incidence of malignant transformation. 
 
Histology.  25% of leukoplakias are having  epithelial dysplasia from 
mild to severe.  In High grade of dysplasia  malignant change more. 
 
Malignant potential.  The chances of leukoplakia becoming 
malignant  are  about 5%.  It  varies according to the site and type of 
leukoplakia and the duration. 
 
Management 
1.  Spontaneous healing when causative agent is removed. 
2.  Biopsy is taken to rule out malignancy. 
3. surgical excision  
4.  ablation with laser or cryotherapy can be done. 
 
3. Proliferative Verrucus leukoplakia (PVL)  
  It is a variant of leukoplakia with white mucosal plaques that 
develop nodular, papillary or verruciform surface projections. 
 Cause -unknown.  
Tobacco usage not proved to be of cause. 
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4. Erythroplakia 
 Similar to leukoplakia, which is a white patch, erythroplakia is a red 
patch or plaque on the mucosal surface.  Red colour is due to decreased 
keratinisation and as a result the red vascular connective tissue of the 
submucosa shines through.   
There is no sex predilection.   
 common sites : lower alveolar mucosa,  
gingivobuccal sulcus and the  
floor of the mouth.   
Most of lesions of erythroplakia show severe dysplasia, carcinoma in situ or 
a frank invasive carcinoma when first seen.   
Malignant potential is 17 times higher than in leukoplakia.   
 Three types of lesions – 1.homogenous 
2.speckled or granular, and  
                                                 3.erythroplakia interspersed with areas of 
leukoplakia. Treatment is excision biopsy and follow up. 
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5. Nicotine Stomatitis  
Nicotine form of keratosis occurring in palate  
Commonly Seen in pipe or cigar smokers 
It appears umbilicated papules with red central depression. 
It is Common in Posterior region of hard palate and soft palates. 
 
6. Actinic Chelitis 
- Solar cheilosis 
- Accelerated tissue degeneration of vermillion partion of lower lip due to 
prolonged exposure to sun. 
 
7. Smokeless tobacco keratosis 
- It is also called as snuff pouch or snuff dippers lesion. 
Clinical  feature is chronic white or gray  translucent mucosal macula 
localized in areas of direct contact with smokeless tobacco. 
Most common sites are  mucobuccal fold of mandible or maxilla in either 
incisor or molar region. 
       Inter twinning their strands or streaks of white kurtosis of bilateral buccal 
mucosa. 
8.Lichen planus :mainly involving buccal mucosa 
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9.Melanosis and mucosal hyperpigmentation Benign pigmented lesions 
of oral mucosa may transform into malignant melanomas; however, the 
incidence of this change is not known.  About one-fourth of mucosal 
melanomas may resemble benign lesions and hence biopsy may become 
mandatory. 
 
MALIGNANT LESIONS OF ORAL CAVITY 
Carcinoma Oral Cavity 
Aetiology 
Compared to western countries, India has high incidence of oral cancers.  
Age adjusted incidence rate in India is 44.8 and 23.7 in males and females, 
respectively.  Compared to 11.2 per 1,00,000 in USA.  Several aetiological 
factors are responsible.  (6-S aetiology, i.e. smoking, spirits, sharp jagged tooth, 
sepsis, syndrome of plummer – vinsion and syphilitic glossitis). 
 
a) Smoking. Incidence of oral cancer is six times more in smokers 
than in non-smokers.  In certain parts of India, there is an 
unusual habit of reverse smoking where burning end of the 
‘churat’ (rolled tobacco leaf) is put in the mouth.  This gives 
high incidence of cancer of the hard palate. 
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b) Tobacco chewing.  Powdered tobacco, mixed with lime, is 
placed in some part of the vestibule of the mouth.  Carcinoma 
develops at the site of the quid.  Chewing “Pan” and keeping 
the quid in the vestibule is largely responsible for oral cancer in 
our country. 
c) Alcohol. Cancer of upper aero-digestive tract occurs six times 
more in heavy drinkers as compared to non drinkers. 
d) Dietary deficiencies. Their role in genesis of cancer has not 
been definitely established.  Riboflavin deficiency may be 
responsible for cancer in alcoholics.  Paterson-Brown-Kelly 
syndrome also called Plummer Vinson syndrome (iron 
deficiency anaemia) is responsible for cancer of the oral cavity 
and hypopharynx. 
e) Dental sepsis, jagged sharp teeth and ill fitting dentures, all 
cause chronic irritation and may lead to development of cancer. 
 
Sites of cancer in the lip and oral cavity are (AJCC 2002) 
1. Mucosal lip (from junction of skin – vermilion border to line of contact 
of upper and lower lip) 
2. Buccal mucosa (includes mucosa of cheek and inner surface of lips up to 
line of contact of opposing lip) 
3. Anterior two thirds of tongue (Oral tongue) 
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4. Hard palate 
5. Lower alveolar ridge 
6. Upper alveolar ridge 
7. Floor of mouth 
8. Retromolar trigone. 
Clinical presentation and treatment of cancer of the oral cavity at 
different sites are described below. 
1. Carcinoma Lip 
 Mostly, it is squamous cell carcinoma, often seen in males in the age 
group of 40-70.  Lower lip is more often involved.  Site of predilection is 
between the midline and commissure of the lip.  Lesion is of exophytic or 
ulcerative type.  Lymph node metastases develop late.  Submental and 
submandibular nodes are the first to be involved; other deep cervical nodes 
may also get involved later. 
 
 Treatment is surgical excision with adequate safety margin of healthy 
tissue and plastic repair of the defect.  Lymph node metastases require block 
dissection. 
 
 Radiotherapy also gives good results in early cases.  Buccal mucosa 
covers a large area.  It extends from the meeting point of lips in front to the 
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pterygomandibular raphe behind and from upper gingivobuccal sulcus to the 
lower one. 
 
 Carcino of buccal mucosa is very common.  Its incidence is next only to 
tongue cancer.  Equally seen in both sexes. 
 
 Site of origin: Most common site is the angle of mouth or the line of 
occlusion of upper and lower teeth.  It may also arise from the buccal sulcus 
where ‘pan’ or tobacco quid is kept.  As the whole of buccal mucosa is 
“condemned”, carcinoma may be multicentric. 
 
 Gross appearance. Lesion may be exophytic or ulceroinfiltrative; the 
latter may infiltrate deeply.  Exophytic type may be associated with 
erythroleukoplakia.  Buccal mucosa is also the most common site for verrucous 
carcinoma which is a white papillary growth with considerable keratinisation. 
 
 Local spread. From its site of origin, the lesion may spread deeply 
involving submucosa → muscle → subcutaneous fat → skin.  Involvement of 
buccinators muscle or anterior masseter causes trismus. 
 
 Tumour may spread radially from its site of origin and involve angle of 
the mouth and lip anteriorly, retromolar trigone and medial pterygoid 
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posteriorly, upper gingi vobuccal sulcus and maxilla superiorly, lower 
gingivobuccal sulcus and alveolar ridge and gums inferiorly. 
 
3. Carcinoma Oral Tongu 
Carcinoma involving anterior two thirds of tongue is commonly seen in 
men in the age group of 50-70 years.  It may also occur in younger age group 
and in females.  It may also develop on a pre-existing leukoplakia, long 
standing dental ulcer or syphilitic glossitis.  Vast majority are squamous cell 
type. 
 
Site. Most common site is middle of the lateral border or the ventral 
aspect of the tongue.  Uncommonly, the tip or the dorsum may be involved. 
 
Spread.  Locally, it may infiltrate deeply into the lingual musculature 
causing ankyloglossia or may spread to the floor of mouth, alveolus and 
mandible.  Lymph node metastases go to the submandibular and upper jugular 
nodes (from the lateral border of tongue) and to the submental and jugulo 
omohyoid group (from the tip).  Bilateral or contralateral nodal involvement 
can also occur. 
 
Clinically, cancer of the oral tongue presents as: 
i) An exophytic lesion like a papilloma. 
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ii) A non-healing ulcer with rolled edges, grayish white shaggy base 
and induration. 
iii) A submucous nodule with induration of the surrounding tissue. 
 
Stage III or IV tumours require combined treatment with surgery and 
post operative radiotherapy.  It gives better results than either modality alone.  
Block dissection neck is always done. 
 
Depending on the size and extent of the primary lesion of the tongue, 
surgery may consist of hemiglossectomy including a portion of the floor of 
mouth, segment or hemimandibulectomy and block dissection of neck nodes 
the so-called “commando operation”. 
 
4. Carcinoma Hard Palate 
It is either squamous cell or variety; the latter being more common.  
Glandular variety arises from minor salivary glands of the palate and may be 
adenoid cystic, mucoepidermoid or adenocarcinoma.  It is common in our 
country especially in people who have the habit of reverse smoking, i.e., 
keeping the burning end of bidi or cigar in the mouth.  Both men and women 
are affected. 
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Cancer starts as a superficial ulcer with rolled out edges and gives no 
symptoms except painless irregularity on the palate felt by the tongue.  It may 
spread to the gingival, lip, soft palate or invade the bone of hard palate, floor of 
the nasal cavity or the antrum.  Lymphatic metastases may spread to the 
submandibular and upper jugular nodes.  Cancer palate should be differentiated 
from cancer of maxillary antrum or nose which has spread to the palate. 
 
5. Carcinoma of Alveolar Ridges 
It is also called gingival carcinoma; it is mostly seen in men.  Usual site 
of involvement is lower jaw behind the first molar.  Tumour may spread to the 
check, floor of mouth, retromolar trigone or the hard palate.  Gingival cancer 
may invade the underlying bone and then spread rapidly along the 
neurovascular bundle.  Nodal metastases go to submandibular and upper 
jugular nodes. 
 
6. Cancer Floor of Mouth 
Squamous cell carcinoma is the most common.  It affects males more 
than females in ratio of 4:1.  Typically, lesions start anteriorly near the opening 
of submandibular duct which may get obstructed, leading to enlargement of 
submandibular gland. 
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Usually, the lesion is ulcerative or infiltrative type and spreads locally 
into the adjoining areas such as ventral aspect of the tongue, lingual gingival, 
mandibular periosteum or deeply into the floor of mouth and submental space.  
Lymphatic metastases go to submandibular nodes.  Lesions of the floor of 
mouth remain asymptomatic for a long time or cause soreness or irregularity in 
the floor of the mouth.  A swelling in the submandibular region may be either 
due to obstructive enlargement of submandibular salivary gland or lymph node 
metastases and this may require differentiation. 
 
7. Carcinoma Retromolar Trigone 
Involvement of retromolar trigone may be primary, or secondary to 
extension of growths from the gingiva, floor of mouth, buccal mucosa or the 
palatine arch. 
 
Treatment depends on the extent of lesion.  Wide surgical excision often 
combined with block dissection is required. 
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5. MATERIALS AND METHODS 
 
Study Design: Randomised Controlled Trail. 
Settings and Subjects: This study includes the patients having  newly 
diagnosed  and histopathologically confirmed Oral submucous fibrosis (OSMF) 
in  Thanjavur Medical College Hospital ,Thanjavur during the period from 
January 2011 to July 2012. 
Sample Size: All the eligible patients according to the inclusion and exclusion 
criteria within the study period will form the study population. It is expected to 
be around 60. 
Inclusion criteria: 
 1. Both males and females. 
 2. Age 13 and above. 
Exclusion criteria: 
 1. Patients with other pre cancerous and cancerous lesions of oral cavity.  
 2. Severe Trismus, Inter incisor distance less than 1cm. 
Outcome Measures:  
         1. Sociodemographic details of Oral submucous fibrosis (OSMF) 
patients. 
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         2. Habits of the patients which are the risk factors of Oral submucous 
fibrosis OSMF have been collected by the history. 
         3. Pre-treatment signs and symptoms are assessed. 
         4. Pre-treatment, post-treatment signs and symptoms are compared.  
 
Data Collection: data collected using pre-tested structured questionnaire. 
  
Data Entry and Analysis:  
 The Data collected will be entered in a Excel Spreadsheet and will be 
analyzed using statistical software SPSS Version 16.  Mean, SD will be 
calculated; ‘t’ test, Chi 2 Test and other appropriate statistical tests will be 
applied.  
  Randomised Control Trail was designed to conduct in our Hospital after 
the protocol was approved by the ethical committee.  
The study consisted totally 60 patients clinically diagnosed and biopsy 
proved as OSMF. Patients with other oral mucosal disorders, systemic 
disorders or those who are not willing to participate in this study were 
excluded. The patients were randomly divided into two groups of 30each, the 
case –group 1 and control –group 2. 
 Each patient was interviewed in detail, with the particular reference to 
the types ,frequency and duration of abusive habits related to the oral cavity 
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.the symptoms and signs were recorded using a 0-4 points visual analogue 
score (VAS). 
Patients were counselled 
• To stop chewing,      
• To avoid unbranded irritant tooth powders, 
• To stop using sharp sticks 
• To use branded tooth paste with their own fingers so that the mucosa 
may not get injured by brush 
Normal mouth opening (interincisor distance)                            
                             Males -5.25 cm 
                             Females -4.75 cm 
Clinically this can be measured by Putting patients own fingers vertically.  
Normal individual can admit his four fingers vertically. 
     GROUP I: (ALPHA LIPOIC ACID GROUP) patients in this group were 
treated with  ALPHA LIPOIC ACID   orally once daily  for 12 weeks  in 
adjunct with  steroid injection of HYDROCORTISONE SODIUM 100mg and 
HYALURONIDASE 1500 IU were given intralesionally as multiple puncture 
weekly once for 12 weeks.  
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 GROUPII:  (NON-ALPHA LIPOIC ACID GROUP) patients in this 
group were treated with steroid injection of HYDROCORTISONE SODIUM 
100mgand HYALURONIDASE 1500 IU were given intralesionally as multiple 
puncture weekly once for 12 weeks .  
All the patients were followed up for 6 months to one year after 
completion of treatment in both groups. There were no dropouts in this study 
and they were all well aware of the fact that they were treated for oral pre-
cancerous condition. 
          Each patient from these two groups was evaluated every week  for 
clinical improvement .Signs and symptoms were compared before the 
treatment and after treatment. 
This study includes the patients having newly diagnosed and 
histopathologically confirmed Oral submucous fibrosis .Most of the patients 
although initially agreed for a post-treatment biopsy, refused biopsy after 
completion of treatment.  
Mangal singh and H.S. Niranjan in their study quoted that “Two groups 
were compared by using interincisor distance and Histopathological 
improvement. This kind of study has not been done so far.”42   
Once diagnosis was made, the treatment was started immediately 
without delay. 
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   6. RESULTS AND OBSERVATION 
 
              6.1 General Characteristics of the Study Population 
 
TABLE 6.1.1  
AGE DISTRIBUTION 
AGE GROUP 
GROUP 
TOTAL 
1 (ALA GROUP) 2 (NON-ALA GROUP) 
Up to 20 Yrs 1 (3.3%) 4 (13.3%) 5 (8.3%) 
21- 30 Yrs 6 (20.0%) 6 (20.0%) 12 (20.0%) 
31- 40 Yrs 9 (30.0%) 9 (30.0%) 18 (30.0%) 
41- 50 Yrs 11 (36.7%) 7 (23.3%) 18 (30.0%) 
51- 60 Yrs 3 (10.0%) 4 (14.3%) 7 (11.7%) 
Total 30 (100%) 30 (100%) 60 (100%) 
 
Chi2 – 2.832   df – 4   p-Value – 0.586 
 
Minimum age of the study group – 14 yrs; Maximum age of the study 
group – 60 yrs; Mean age of group I – 39 yrs; Mean age of group II -37 yrs; 
and Over all Mean   - 38.30 yrs.  
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FIGURE 6.1.1 
MULTIPLE BAR CHART SHOWING AGE DISTRIBUTION OF THE 
STUDY POPULATION 
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TABLE 6.1.2 
SEX DISTRIBUTION 
SEX 
GROUP 
TOTAL 
1 2 
MALE 12 (40.0%) 17 (56.7%) 29 (48.3%) 
FEMALE 18 (60.0%) 13 (43.3%) 31 (51.7%) 
Total 30 (100%) 30 (100%) 60 (100%) 
Chi2 – 1.669   df – 1   p-Value – 0.196 
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Fig. 6.1.2  
MULTIPLE BAR CHART SHOWING SEX DISTRIBUTION 
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6.1.3 EDUCATION  
EDUCATION GROUP 
GROUP 
TOTAL 
1 2 
NIL 5 (16.7%) 7 (23.3%) 12 (20.0%) 
PRIMARY 14 (46.7%) 7 (23.3%) 21 (35.0%) 
MIDDLE 2 (6.7%) 2 (6.7%) 4 (6.7%) 
HIGH 3 (10.0%) 11 (36.7%) 14 (23.3%) 
HIGHER SECONDARY 3 (10.0%) 1 (3.3%) 4 (6.7%) 
DEGREE 3 (10.0%) 2 (6.7%) 5 (8.3%) 
Total 30 (100%) 30 (100%) 60 (100%) 
 
Chi2 – 8.438   df – 5   p-Value – 0.134 
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6.2 CHARACTERISTICS RELATED TO OSMF 
TABLE 6.2.1 
PERSONAL HABITS 
PERSONAL 
HABITS 
GROUP 
TOTAL Chi
2 
- 
Value 
p-
Value 
1 2 
TOBACCO 9 (30.0%) 
7 
(23.3%) 16 (26.7%) 0.341 0.559 
BETELNUT 3 (10.0%) 1 (3.3%) 4 (6.7%) 1.071 0.301 
BL,BN,LIME 17 (56.7%) 
11 
(36.7%) 28 (46.7%) 2.411 0.121 
PAN 
MASALA 4 (13.3%) 7 (23.3%) 11 (18.3%) 1.002 0.317 
FABRICATED 5 (20.0%) 11 (36.7%) 17 (28.3%) 2.052 0.152 
ALCOHOL 2 (6.7%) 1 (3.3%) 3 (5.0%) 0.351 0.554 
SMOKING 6 (20.0%) 5 (16.7%) 11 (18.3%) 0.111 0.739 
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FIG. 6.2.1 
COMPONENT BAR CHART SHOWING THE PERSONAL HABITS  
OF THE STUDY POPULATION 
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TABLE 6.2.2 
SYMPTOMS RELATED TO OSMF 
 
SYMPTOMS 
GROUP 
TOTAL Chi
2 
Value 
p-
Value 
1 2 
BURNING 28 (93.3%) 
29 
(96.7%) 
57 
(95.0%) 0.351 0.554 
DRYNESS 27 (90.0%) 29 (96.7%) 56 (93.3%) 0.278 0.302 
TRISMUS 30 (100%) 30 (100%) 60 (100%) - - 
BLANCHING 30 (100%) 30 (100%) 60 (100%) - - 
FIBROUS BAND 28 (93.3%) 30 (100%) 58 (96.7%) 0.523 0.472 
ANKYLOGLOSSIA 26 (86.7%) 26 (86.7%) 52 (86.7%) 0.000 1.000 
STOMATITIS 24 (80.0%) 25 (83.3%) 49 (81.7%) 0.111 0.739 
SOFT PALATE 25 (83.3%) 24 (80.0%) 49 (81.7%) 0.137 0.718 
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FIGURE 6.2.2.  
MULTIPLE BAR CHART SHOWING SYMPTOMS OF  
OSMF IN BOTH GROUPS 
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TABLE 6.2.3 
ORAL HYGIENE 
ORAL 
HYGIENE 
GROUP 
TOTAL 
1 2 
POOR 15 (50.0%) 17 (56.7%) 32 (53.3%) 
FAIR 13 (43.3%) 11 (36.7%) 24 (40.0%) 
GOOD 2 (6.7%) 2 (6.7%) 4 (6.7%) 
Total 30 (100%) 30 (100%) 60 (100%) 
Chi2 – 0.292   df – 2   p-Value – 0.864 
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FIGURE 6.2.3 
MULTIPLE BAR CHART SHOWING ORAL HYGIENE  
PATTERN IN BOTH GROUPS 
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TABLE 6.2.4 
MATERIAL FOR BRUSHING TEETH 
MATERIAL FOR 
BRUSHING TEETH 
GROUP 
TOTAL 
1 2 
SHARP STICK 7 (23.3%) 4 (13.3%) 11 (18.3%) 
TOOTH PASTE 11 (36.7%) 11 (36.7%) 22 (36.7%) 
UNBRANDED 12 (40.0%) 15 (50.0%) 27 (45.0%) 
Total 30 (100%) 30 (100%) 60 (100%) 
Chi2 – 1.152   df – 2   p-Value – 0.562 
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FIGURE 6.2.4 
PIE CHART SHOWING THE MATERIALS  
USED FOR BRUSHING TEETH 
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TABLE 6.3 
DESCRIPTIVE STATISTICS 
 
 GROUP 1 GROUP 2 OVERALL F - Value 
p - 
Value 
AGE IN 
YEARS 
39.23 ± 
10.54 
37.37 ± 
12.66 
38.30 ± 
11.59 0.385 0.537 
DISTANCE 
in Kms 
23.33 ± 
13.88 
19.73 ± 
15.49 
21.48 ± 
14.17 0.913 0.343 
INCOME in 
Rs 
4208.33 ± 
4036.52 
4616 ± 
2935.17 
4412.50 ± 
3505.09 0.201 0.656 
HB in mg% 8.98 ± 1.48 8.38 ± 1.44 8.68 ± 1.48 2.573 0.114 
TOTAL 
COUNT 6768 ± 2230 6615 ± 2827 6692 ± 2525 0.055 0.816 
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TABLE 6.4 
MEAN PRE- TREATMENT SCORE 
 
 GROUP 1 GROUP 2 OVERALL  F - Value p - Value 
PRE BURNING 3.00 ± 1.15 3.20 ± 0.66 3.10 ± 0.93 0.685 0.411 
PRE DRYNESS 2.97 ± 1.13 3.20 ± 0.66 3.08 ± 0.93 0.952 0.333 
PRE TRISMUS 3.30 ± 0.79 3.40 ± 0.56 3.35 ± 0.68 0.316 0.576 
PRE BLANCHING 3.47 ± 0.63 3.47 ± 0.62 3.43 ± 0.62 0.171 0.681 
PRE FIBROUS 3.33 ± 0.88 3.20 ± 0.81 3.27 ± 0.84 0.371 0.544 
PRE 
ANKYLOGLOSSIA 3.00 ± 1.11 2.53 ± 1.52 2.77 ± 1.35 1.831 0.181 
PRE STOMATITIS 2.73 ± 1.36 2.33 ± 1.54 2.53 ± 1.46 1.136 0.291 
PRE SOFT 
PALATE 2.70 ± 1.34 2.20 ± 1.49 2.45 ± 1.43 1.857 0.178 
PRE TOTAL 24.50 ± 6.04 
23.47 ± 
5.92 
23.98 ± 
5.98 0.447 0.506 
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TABLE 6.5  PAIRED T-TEST FOR GROUP 1 
 * Statistically Significant (p -Value < 0.001) 
 
There is statistically significant difference in all the individual 
symptoms and overall symptoms between pre treatment and post treatment of 
alpha lipoic acid group (group I), Statistically Significant (p -Value < 0.001). 
 
 
 Mean Std. Deviation t - Value Significance 
Pair 1 
PRE BURNING 3.00 1.145 
9.607 0.000* 
POST BURNING 1.57 .935 
Pair 2 
PRE DRYNESS 2.97 1.129 
9.424 0.000* 
POST DRYNESS 1.57 .935 
Pair 3 
PRE TRISMUS 3.30 .794 
9.633 0.000* 
POST TRISMUS 1.97 .809 
Pair 4 
PRE BLANCHING 3.47 .629 
11.366 0.000* 
POST BLANCHING 2.07 .868 
Pair 5 
PRE FIBROUS 3.33 .884 
10.420 0.000* 
POST FIBROUS 1.97 .999 
Pair 6 
PRE 
ANKYLOGLOSSIA 3.00 1.114 6.901 0.000* POST 
ANKYLOGLOSSIA 1.87 1.137 
Pair 7 
PRE STOMATITIS 2.73 1.363 
6.998 0.000* 
POST STOMATIS 1.70 1.179 
Pair 8 
PRE SOFT PALATE 2.70 1.343 
6.595 0.000* 
POST SOFT PALATE 1.70 1.179 
Pair 9 
PRETOTAL 24.50 6.044 
12.103 0.000* 
POSTTOTAL 14.43 6.585 
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TABLE 6.6 
PAIRED T-Test FOR GROUP 2 
* Statistically Significant (p -Value < 0.05) 
 
 Mean Std. Deviation t - Value Significance 
Pair 1 
PRE BURNING 3.20 .664 
10.933 0.001* 
POST BURNING 1.90 .712 
Pair 2 
PRE DRYNESS 3.20 .664 
10.933 0.001* 
POST DRYNESS 1.90 .712 
Pair 3 
PRE TRISMUS 3.40 .563 
11.948 0.002* 
POST TRISMUS 2.10 .662 
Pair 4 
PRE BLANCHING 3.40 .621 
11.894 0.000* POST 
BLANCHING 2.13 .681 
Pair 5 
PRE FIBROUS 3.20 .805 
10.865 0.000* 
POST FIBROUS 2.07 .740 
Pair 6 
PRE 
ANKYLOGLOSSIA 2.53 1.525 4.805 0.000* POST 
ANKYLOGLOSSIA 1.70 1.088 
Pair 7 
PRE STOMATITIS 2.33 1.539 
4.955 0.000* 
POST STOMATIS 1.43 1.104 
Pair 8 
PRE SOFT 
PALATE 2.20 1.495 4.817 0.000* POST SOFT 
PALATE 1.53 1.042 
Pair 9 
PRETOTAL 23.47 5.923 
13.310 0.000* 
POSTTOTAL 14.87 5.532 
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TABLE 6.7 
 
COMPARISON OF DIFFERENCE IN SIGNS AND SYMPTOMS 
SCORE BETWEEN TWO GROUPS 
* Statistically Significant (p -Value < 0.05) 
 
 There is statistically significant difference in all the individual 
symptoms and overall symptoms between alpha lipoic acid group (group I) and 
Non-alpha lipoic acid group.  Statistically Significant (p -Value < 0.05) 
 
 
 GROUP 1 GROUP 2 OVERALL F - Value 
p - 
Value 
DIF BURNING 1.43 ± 0.82 1.07 ± 0.52 1.25 ± 0.71 4.295 0.043* 
DIF DRYNESS 1.40 ± 0.81 0.90 ± 0.31 1.15 ± 0.66 9.932 0.003* 
DIF TRISMUS 1.33 ± 0.76 1.00 ± 0.37 1.17 ± 0.62 4.677 0.035* 
DIF BLANCHING 1.40 ± 0.66 1.00 ± 0.37 1.20 ± 0.56 8.093 0.006* 
DIF  FIBROUS 1.37 ± 0.72 0.90 ± 0.61 1.13 ± 0.70 7.382 0.009* 
DIF 
ANKYLOGLOSSIA 1.23 ± 0.86 
0.57 ± 
0.57 0.90 ± 0.79 12.581 0.001* 
DIF STOMATITIS 1.03 ± 0.81 0.57 ± 0.63 0.80 ± 0.76 6.246 0.015* 
DIF SOFT PALATE 1.00 ± 0.83 0.47 ± 0.51 0.73 ± 0.73 9.010 0.004* 
DIF TOTAL 10.13 ± 4.58 
7.53 ± 
3.91 8.83 ± 4.42 5.596 0.021* 
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                               7. DISCUSSION 
60 cases in this study are in age group of 13 to 60, with majority of them 
fell in 40-50 years of life. 
Minimum age of the study group is 14 ,Maximum age of the study 
group – 60,Mean age of group I – 39,Mean age of group II -37 ,And the 
Overall mean age   -38.30 
Out of 60 cases 29were males and 31 were females, Males and females 
are almost equal in numbers. 
Only 6.7% studied up to higher secondary school, 35% of them studied up to 
primary school, 5% are studied in college, and 20% of them are uneducated. 
There is no significant difference in education pattern among two groups.                 
 p-Value >0.05            
There is no significant difference in education pattern among two 
groups.                
 p-Value >0.05 table 6.1.3 
Personal habits are closely related with this disease. Following habits 
were observed   16 patients have taken tobacco, 4 patients have taken betel nut, 
and 28 patients have taken betel leaf, betel nut and lime. 11 patients have taken 
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pan masala, 17 patients have taken fabricated betel nut, 3 patients have taken 
alcohol and 11 were smokers .As it is seen in the table 6.2.1 these personal 
habits are almost equally distributed in both groups.  p-Value >0.05. 
This study includes the patients having newly diagnosed and 
histopathologically confirmed Oral submucous fibrosis .Most of the patients 
although initially agreed for a post-treatment biopsy, refused biopsy after 
completion of treatment.  
86.7% of people in this study population were having Angular 
Stomatitis is the state of nutritional deficiency. It may synergize the disease 
condition in contributing to epithelial atrophy.                                                                             
Almost all the patients in the study population were chewing betel nut in 
various forms. Majority of them chewed betel nut with betel leaf and lime. 
All the patients in this study were having trismus and blanching of oral 
mucosa, and 96.7% of them were having fibrous band and 93.3% having 
dryness of mouth. 
Out of 60 patients only 4 patients were having good oral hygiene; it is 
6.4% in the study group, 53.3% of them having poor oral hygiene and 40% of 
them having fair oral hygiene. 
In this study nearly 50% of the patients were using unbranded powders 
for brushing their teeth. This will irritate the mucosa and may aggravate the 
disease process, and 18.3% of patients were using sharp sticks, 
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Mean value of Age of the patient, Distance from health care, Income, 
Haemoglobin% and Total White Blood Cell count were studied in this study. 
There is no difference in distribution of the mean value of these above 
factors between two groups 
Symptoms and signs were observed in this study group,95%of the total 
study group had burning sensation, 93.3% -dryness of mouth, and 100% ,that is 
all 60 patients presented with trismus and blanched mucosa, 96.7% of patients 
had fibrous band, 86.7% had ankyloglossia, 81.7% had angular stomatitis and 
81.7% had soft palate involvement.  There is no significant difference in 
prevalence of symptoms and signs were observed in both groups as   p-Value 
>0.05. 
With available studies these symptoms and signs were seen in more than 
80% of study groups.   
Oral hygiene is the index of the severity of OSMF; only 4 patients were 
having good oral hygiene, it is 6.4% in the study group, 53.3% of them having 
poor oral hygiene and 40% of them having fair oral hygiene. Oral hygiene is 
also equally distributed in both groups. There is no significant difference 
between two groups.   P-Value >0.05. 
In this study nearly half of the patients were using unbranded powders 
for brushing their teeth. This will irritate the mucosa and may aggravate the 
disease process. and 18.3% of patient were using sharp sticks ,these sharp ends 
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of the stick will produce more and more damage to mucosa as evident in table 
6.2.4  and there is no significant difference were observed between two groups   
p-Value >0.05. 
In this study Age of the patient, Distance from health care, Income, 
Hemoglobin% and total WBC count were also taken into consideration. There 
is no difference in distribution of the mean value of these above factors 
between two groups. 
We can assume that all the factors mentioned above are not playing their 
role while interpreting the treatment outcome of these two groups. 
In table 6.4 mean pre-treatment signs and symptoms score between 
group 1 and group 2 were compared. And found that both these group are very 
much comparable before treatment. 
Pre-treatment and post-treatment signs and symptoms score of group 1 
compared with paired t-test. And it revealed that, all the individual signs and 
symptoms and overall signs and symptoms showed highly significant 
difference between pre-treatment and post-treatment score. It is shown in table 
6.5   p-Value <0.001. 
Based on the result given in the table 6.5 Alpha lipoic acid is highly 
effective when used with injection hydrocortisone sodium and hyaluronidase. 
         While comparing Pre-treatment and post-treatment signs and symptoms 
score of group 2 compared with paired t-test, highly significant difference 
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noted in Blanching, Fibrous Band, Ankyloglossia and Angular Stomatitis. (p- 
Value <0.001) 
And in Burning sensation Dryness of mouth and Trismus were 
significant only (p-value <0.01) .it shows that group 2( Non ALAgroup) is also 
effective but not to the level where ALA group as it is evident by p-value. This 
observation is confirmed by the table 6.6 
Difference in the signs and symptoms of pre-treatment and post 
treatment between the two groups were compared, there is statistically 
significant difference in all the  signs and  symptoms  of pre-treatment and post 
treatment score between alpha lipoic acid group (group I) and Non-alpha lipoic 
acid group.  Statistically Significant (p -Value < 0.05) according to the table 6.7 
The following should be implemented by the Government the Ministry of 
social welfare and other organizations and also by medical professionals to 
prevent and control the progression of disease.  The operation should be started 
at the root. 
1. Where products are manufactured.  Generally they are small scale 
industries, run by people of a locality.  They should be trained for their 
earning in some other job. 
2. Where these plants are cultivated.  Other than a small number of people 
for whom betel, tobacco plant cultivation is the major occupation, large 
group of people do this as an accessory work in their fields where they 
grow trees, palm casuarinas etc. 
76 
 
3. The channel through which they are transported and sold. 
4. Sale near residential and educational places should be banned. 
5. Prohibition in cinemas, mass education regarding adverse effects.  In 
town areas, passing information, communication and educating people is 
easier than in villages where social workers should go and talk to a 
gathering, in schools and in places where people gather during function 
and festival. 
6. So as for smoking, strict rules should be implemented for pan masala, 
tobacco chewing and spitting in public places like hospitals, cinema 
theatres and from running buses on road side. 
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8. CONCLUSION 
To conclude, both educated and uneducated people are getting affected 
knowingly or unknowingly.  Even if some people realize, they could not come 
out from this habit due to addiction. 
Areca nut and tobacco are the precipitating factors. Therefore preventive 
measures must be taken  
These products are neither bearing proper labels nor the health 
warnings. 
          Pre-treatment and post-treatment signs and symptoms score of ALA-
Group compared with paired t-test. And it revealed that, all the individual signs 
and symptoms and overall sign and symptoms were highly significant. 
In younger individuals, popularity of commercially available products 
are on the rise rather than traditional betel quid, leading to adoption of this 
habit at a younger age. 
Even though the educated people in the study populations are habitual 
chewers, there is a need for proper health education in our community. 
According to the table 6.3 nearly 20% of study populations are not 
educated and only 8.3% are having degree and only 35% of them studied up to 
primary school. 
There is definite improvement in the symptom especially burning 
sensation of mouth and mouth opening that is interincisor distance measured 
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with a caliber in all patients who were included in this study. Mean  Pre-
treatment  trismus score in group I is -3.3   has became reduced after treatment 
as 1.97,whereas Mean Pre-treatment  trismus score in group II  is 3.4  has 
become reduced after treatment as 2.1   It reveals the efficacy of the therapy to 
the patient.  
             And at the end of the study a significant difference between the two 
groups were observed .Even though there is clinical improvement in both these 
groups, ALA group is proved to be better than Non ALA group. A statistically 
significant difference has been observed. 
 In our hospital set up,  
• we colleagues advice and also make patients who come with 
tobacco stained tooth, in earlier stage of the disease, to stop this 
habit which is only 50% fruitful with our maximum care. 
• Last, but not the least, there should be individual awareness and 
motivation to restrain from this habit. 
 
The antioxidant Alpha lipoic acid, has a definitive protective role as 
demonstrated in this study, and it can certainly be recommended for clinical 
use as routine. 
 
  
 9. BIBLIOGRAPHY 
 
1. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. 19. Oral Surg Oral Med 
Oral Pathol 1966; 22: 764-79.]   
 
2 Desirée Rosa Cavalcanti and Fernando Ricardo Xavier da Silveira J Oral 
Pathol Med 38(3):254-61 (2009) PMID 19175713  
 
3. Cunningham’s manual of human anatomy,head and neck 329-333 
 
4. Text book of pathology Robbins and Cotran  
 
5. SURGICAL PATHOLOGY of Head and Neck INFORMA Vol 1:267 
 
6. World article in ear, Nose and Throat-sudhakar vaidya  
7. Cookbook: Pan Masala – Wikibooks. Retrieved Feb. 15, 2009 from 
http://en.wikibooks.org/wiki/Cookbook:Pan_Masala . 
8. "IARC Monographs Programme finds betel-quid and areca-nut chewing 
carcinogenic to humans". World Health Organization. 200^  
9.OriginalArticles Oral submucous fibrosis in India: A new epidemic? 
P. C. GUPTA, P. N. SINOR, R. B. BHONSLE, V. S. PAWAR, H. C. MEHTA 
 
10.  Cannif JP, Harvey W –pathology and management of OSMF in Br.Dent J 
1986:160. 
 
11. (Ref View A^ Pindborg JJ. Oral submucous fibrosis: a review. Ann Acad 
Med Singapore. 1989 Sep; 18(5):603-7. Bstract) 
 
12.  Head And Neck Oncology 2009; 1:10, Article Published Online 2009 May 
2 Histopathological Staging Of OSMF 
13. Bakhshi GD, Langade D, Subnis BM.   Comparative Evaluation of Human 
Placental Extract for its Healing Potential in Surgical Wounds (An Open, 
Randomized, Comparative Study): Bombay Hospital Journal: Volume 49 No. 
03, July 2007  
14. Cannif et al 1958, Tilakaratne et ai, 2005 review article M.K.Gupta 
People’s journal of scientific Research july2008. 
15. Oral submucous fibrosis - Current Concepts in Etiopathogenesis 
M.K. Gupta*, Shubhangi Mhaske, Raju Ragavendra, Imtiyaz 
16. new adjuncts in the treatment of OSMF – INDIAN DENT J Res Oct 2006 
  
17. Gupta Prakash Chandra, Ray Cecily S (July 2004). "Epidemiology of betel 
quid usage". Ann. Acad. Med. Singap. 33 (4 Suppl): 31–6. PMID 15389304. 
http://www.annals.edu.sg/pdf200409/V33N4p31S.pdf3 
18. Mangal Singh, H.S. Niranjan- Efficacy of hydrocortisone acetate/ 
hyaluronidase vs. triamcinolone acetonide/hyaluronidase in the treatment of 
oral submucous fibrosis, Indian J Med Res 131, May 2010, pp 665-669)  
19. Oral surg, oral med oral patho oral radio feb 2007 
20. Sharma JK et al. Clinical experience with the use Of peripheral vasodilator 
in oral disorders. Int. j. Oral max. fac. surg., 1987, 16: 695-699. 
 
21. Bhonsle RB.international symposium 1990: Oxford univ press 1992 
 
22. Cox SC, Walker DM (Oct 1996). "Oral submucous fibrosis a review". Aust 
Dent J. London 41 (5): 294–9 
 
23. Cox SC, Walker DM. Establishing a normal range for mouth opening: its 
use in screening for oral submucous fibrosis. Br J Oral Maxillofac Surg 
19973540-2.  
 
24. Gupta D, Sharma SC. Oral submucous fibrosis: a 
new treatment regimen. J. oral max. fac. surg., 1990, 46: 830-833. 
25. Abraham S, Sankaranarayanan S, Padmanaban J , Srinivasan V, Senthil 
Nagarajan R, Murugan P, Manjunath S, Senthil Kumar R, Baskar S (June 
2008). "Autologous Bone Marrow Stem Cells in Oral Submucous Fibrosis – 
Our experience in three cases with six months follow-up". 8th Annual Meeting 
of Japanese Society of Regenerative Medicine, Tokyo, Japan 68 (12): 233–55. 
26. Cochrane Review 2008.  Interventions for the Management of Oral Sub-
Mucous Fibrosis 
27. Gupta D, Sharma SC. Oral submucous fibrosis: a new treatment regimen.J. 
oral max. fac. surg., 1990, 46: 830-833.  
 
28. M.K. Gupta*, Shubhangi Mhaske, Raju Ragavendra 
29  . Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, GuptaPC, Mehta FS.: 
Malignant transformation rates in oral Submucous fibrosis over a 17 year 
period. Community Dentistry & Oral Epidemiology, 1985; 13:340–341. 
 
30. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous 
fibrosis in India: a new epidermic.  National Medical Journal of India, 
1998;11:113–116. 
  
  
31. Rajendran R.: Oral submucous fibrosis: etiology, pathogenesis and future 
research. Bulletin of World 
 
32. Pindborg JJ, Sirsat SM.: Oral submucous fibrosis. Oral Surgery Oral 
Medicine & Oral Pathology, 1966; 22: 764–779.  
 
33.  P. C. GUPTA, P. N. SINOR, R. B. BHONSLE, V. S. PAWAR, H. C. 
MEHTA Oral submucous fibrosis in India: A new epidemic. 
 
34. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta HC. Oral submucous 
fibrosis in India: a new epidermic. National Medical Journal of India, 
1998;11:113–116.  
 
35. International Agency for Research on Cancer (IARC).: Betel-quid and 
areca nut chewing and some areca nut derived nitrosoamines. Lyon IARC, 
2004; 85: 123–129. 
 
36. Bhonsle RB, Murti PR, Gupta PC. Tobacco habits in India. In: Gupta PC, 
Hamner IE. Murti PR (eds), Control of tobacco- related cancers and other 
disease s. Proceedings of an international symposium, 15-19 January. 1990. 
Bombay.Oxford University Press, 1992:25- 
 
37. Kerr AR. Efficacy of oral Lycophene in the management of oral submucous 
fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103:214-  
38. Desirée Rosa Cavalcanti and Fernando Ricardo Xavier da Silveira J Oral 
Pathol Med 38(3):254-61 (2009) PMID 19175713 Tweet  
 
 39. Br J Cancer. 2003 February 10; 88(3): 366–372 
40. Rajendran R et al. Total haemolytic complement (CH50) and its fractions 
(C3 and C4) in the sera of patients with pre-malignant and malignant lesions of 
oral cavity. Ann. dent., 1990, 48: 36-38. 
 
41. Indian J Med Res 131, May 2010, pp 665-669Efficacy of hydrocortisone 
acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the 
treatment of oral submucous fibrosisMangal Singh, H.S. Niranjan, Ravi 
Mehrotra*, Devashish Sharma** & S.C. Gupta 
 
42. M.K. Gupta, Shubhangi Mhaske, Raju Ragavendra, Imtiyaz THE 
NATIONAL MEDICAL JOURNAL OF INDIA VOL. 11, No.3, 1998. 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 4.9 
GRADE 3-section shows minimal sub epithelial fibroblast proliferation and  
Collagen is moderately hyalinised, and blood vessels are constricted 
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Figure 4.8 
GRADE 2- section shows hyperplastic squamous epithelium, sub-epithelium  
shows fibroblastic proliferation with collagen deposition. 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 4.7 
GRADE 1-section shows hyperplastic squamous epithelium, sub-epithelium shows 
acute inflammatory cells, minimal fibroblastic proliferation and congested blood 
vessels. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 4.10 
    MARBLE LIKE APPEARANCE OF ORAL MUCOSA IN A  
PATIENT WITH OSMF 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.11 
TRISMUS  IN A 19 YRS OLD CHRONIC CHEWER 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.12 
THE ABOVE SAID PATIENT  WITH MARBLE  COLOURED  BUCCAL  
MUCOSA  INVOLVING SOFT PALATE , TONSILLAR PILLARS 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 4.2 
CONICAL / ROUNDED BROWNISH UNPROCESSED FRESH  
FORM OF BETEL NUT 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.4 
SHARP EDGES CAUSE MORE DAMAGE TO MUCOSA,  
FORCE NEEDED TO CRUSH THE HARD NUTS 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.3 
NATURALLY AVAILABLE FORM OF BETEL LEAF, BETEL NUT AND TOBACCO, 
IMPROPERLY LABELLED SWEETENED PACKED FORM OF BETEL NUT. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.5 
PACKED TOBACCO AND GUTKHA-IN ATTRACTIVE  
FORM AVAILABLE IN THE MARKET 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.13 
CALIBER USED TO MEASURE INTERINCISOR DISTANCE  
IN A CASE OF OSMF 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.14 
WOODEN PAMBARAM USED FOR MOUTH OPENING EXERCISE 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 4.6 
DEPARTMENTAL SHOPS SELLING PROCESSED PACKED TOBACCO  
ALONG WITH OTHER NUTRITIONAL SUBSTANCES 
 
 
 
 
 
 
                     
  
 
 
 
 
 
 
NORMAL ORAL MUCOSA 
 
 
   
Figure 4.1(A) 
NORMAL ORAL MUCOSA-STRATIFIED SQUAMOUS EPITHELIUM SUPPORTED 
BY A LAMINA PROPRIA, UNDER THE MUCOSA THERE IS TOUGH 
SUBMUCOSAL LAYER WITH SALIVARY GLANDS. 
 
 
 
  
 
 
 
 
 
 
 
Figure 4.15 
INTRALESIONAL    INJECTION    HYDROCORTISONE   AND  
HYALURONIDASE BEING INJECTED TO A PATIENT WITH OSMF 
 
 
 
 
  
 
   
 
 
 
 
 
 
 
 
 
Figure 4.17 
PRE-TREATMENT PICTIRE OF A PATIENT WITH OSMF SHOWING 
TRISMUS AND ANGULAR STOMATITIS 
Figure 4.18 
POST TREATMENT PICTURE OF THE PATIENT SHOWING 
IMPROVEMENT IN TRISMUS 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19 
PRE-TREATMENT PICTIRE OF A PATIENT WITH OSMF  
SHOWING TRISMUS AND HYPER PIGMENTATION 
Figure 4.20 
POST TREATMENT PICTURE OF THE PATIENT  
SHOWING IMPROVEMENT IN TRISMUS 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1(B) 
ORAL CAVITY AND OROPHARYNX 
  
 
 
 
 
 
 
Figure 4.1(C) 
MEDIAL SAGITTAL VIEW OF OROPHARYNX 
  
 
 
 
 
 
 
Figure 4.16 
INJECTION SITES 
OSMF - MASTER CHART
S
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1 1 VALAVAMBAL 60 FEMALE 25 NIL NIL COOLIE 2,000   3,3    Y Y Y Y N Y N N
2 1 VINAYAKI 48 FEMALE 25 NIL NIL COOLIE 2,000  24,6     Y Y Y Y Y Y Y Y
3 1 KADALMANI 35 FEMALE 30 NIL NIL COOLIE 2,000   15,5    Y Y Y Y Y Y Y Y
4 1 GANDHIMATHI 41 FEMALE 10 5 PRIMARY H.W 0   3,5    Y Y Y Y Y Y Y Y
5 1 SHAKILA 45 FEMALE 50 5 PRIMARY H.W 0 2,5  2,5    Y Y Y Y Y Y Y Y
6 1 NAGAMMAL 30 FEMALE 15 4 PRIMARY COOLIE 3,000     3,5  N N Y Y Y Y Y Y
7 1 ANJAMMAL 45 FEMALE 35 2 PRIMARY VENDOR 10,000     10  Y Y Y Y Y Y Y Y
8 1 INDRANI 45 FEMALE 25 NIL NIL COOLIE 3,000 25,5  25,5    Y Y Y Y Y Y Y Y
9 1 PAPPA 55 FEMALE 17 NIL NIL COOLIE 3,500   30,5    Y Y Y Y Y Y Y Y
10 1 SIVABAKIYAM 50 FEMALE 32 2 PRIMARY COOLIE 4,500 8,5  8,5    Y Y Y Y Y Y Y Y
11 1 PARVATHY 45 FEMALE 16 5 PRIMARY COOLIE 3,000 20,5  20,5    Y Y Y Y Y Y Y Y
12 1 UTHIRAPATHY 34 MALE 19 8 MIDDLE TAILOR 8,000    3,10  12 12,5 Y Y Y Y Y Y Y Y
13 1 SELVI 39 FEMALE 20 5 PRIMARY COOLIE 3,000 20,5  20,5    Y Y Y Y Y Y Y Y
14 1 KAMALAHASAN 15 MALE 65 8 MIDDLE H.SERVER 2,750    3,10   Y Y Y Y Y Y Y Y
15 1 NEELAVATHY 40 FEMALE 18 3 PRIMARY COOLIE 3,500     10,10  Y Y Y Y Y Y Y Y
16 1 BASHARAN 50 MALE 10 PUC DEGREE SALES MAN 20,000 20,5 20,5     Y Y Y Y Y Y Y Y
17 1 PREM 29 MALE 56 12 HIGER SECONDARY BUS CON 5,000    2,10   Y Y Y Y Y Y N N
18 1 YESURAJ 22 MALE 7 12 HIGER SECONDARY COOLIE 5,000     2,10  Y N Y Y Y Y Y Y
19 1 SUNDARAMBAL 27 FEMALE 22 5 PRIMARY COOLIE 5,000     2,10  Y Y Y Y Y Y Y Y
20 1 RAJENDRAN 45 MALE 23 5 PRIMARY COOLIE 7,000 20,5 20,5     Y Y Y Y Y Y Y Y
21 1 DURAIMANIKAM 34 MALE 25 5 PRIMARY COOLIE 4,500   10,5   10 10,5 Y Y Y Y Y N N N
22 1 PRABU 28 MALE 30 BBA DEGREE STUDENT 0    1   Y Y Y Y Y N N N
23 1 MAHALAKSMI 37 FEMALE 15 10 HIGH HW 0   15,10    Y Y Y Y Y Y Y Y
24 1 VASANTHA 45 FEMALE 29 3 PRIMARY COOLIE 4,500   25,8    Y Y Y Y Y Y Y Y
25 1 ARUN KARTHI 22 MALE 22 DECE DEGREE STUDENT 0     1 1 Y Y Y Y N N N N
26 1 DHARMARAJ 55 MALE 12 10 HIGH COOLIE 5,000   ,30,10   20,24 N N Y Y Y Y Y Y
27 1 RANI 39 FEMALE 5 3 PRIMARY HW 0 10,10  10,10    Y Y Y Y Y Y Y Y
28 1 SUNDARARAJAN 35 MALE 15 10 HIGH COOLIE 10,000   10,5   10,10 Y Y Y Y Y Y Y Y
29 1 RAMESH 37 MALE 15 12 HIGER SECONDARY WATCH MAN 5,000 17,5  17,5   10,5 Y Y Y Y Y Y Y Y
30 1 MEENA 45 FEMALE 9 5 PRIMARY COOLIE 5,000   20,7    Y Y Y Y Y N N N
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1 VALAVAMBAL POOR UNBRANDED 11 6,700 69 27 3 3 1 3 0 3 0 0 1 1 1 1 0 1 0 0
2 VINAYAKI POOR UNBRANDED 9 6,200 67 29 4 4 4 3 3 3 3 3 3 1 1 1 1 1 1 1 1
3 KADALMANI POOR UNBRANDED 9 7,400 66 31 3 3 3 3 3 3 3 3 3 1 1 2 2 2 2 2 2
4 GANDHIMATHI POOR SHARP STICK 8 6,500 63 33 4 3 3 4 4 4 4 4 4 2 2 3 3 3 3 3 3
5 SHAKILA FAIR TOOTH PASTE 10 4,000 56 41 3 4 4 4 4 4 3 3 3 2 2 3 3 3 3 2 2
6 NAGAMMAL FAIR SHARP STICK 10 7,500 69 28 3 0 0 3 3 3 2 2 2 0 0 2 2 2 2 2 2
7 ANJAMMAL FAIR TOOTH PASTE 9 3,400 57 40 3 4 4 4 4 4 3 4 4 1 1 2 2 2 2 2 2
8 INDRANI POOR SHARP STICK 10 6,400 56 40 4 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2
9 PAPPA POOR UNBRANDED 7 9,600 70 26 4 3 3 3 4 4 4 4 4 1 1 3 4 4 4 4 4
10 SIVABAKIYAM FAIR TOOTH PASTE 10 7,000 68 30 2 4 4 4 4 4 3 4 4 3 3 3 3 3 3 3 3
11 PARVATHY POOR UNBRANDED 13 6,200 58 38 4 3 3 2 3 3 3 2 2 1 1 1 1 1 1 1 1
12 UTHIRAPATHY FAIR TOOTH PASTE 12 6,200 58 38 4 4 3 4 4 4 4 4 4 2 2 2 2 2 2 2 2
13 SELVI POOR UNBRANDED 10 6,700 61 36 3 4 4 4 4 4 4 4 4 3 3 3 3 3 3 3 3
14 KAMALAHASAN FAIR TOOTH PASTE 8 8,000 65 22 3 3 3 3 3 3 3 3 3 1 1 1 1 1 1 1 1
15 NEELAVATHY POOR SHARP STICK 10 6,800 62 25 3 3 3 3 4 4 4 4 4 1 1 2 2 2 3 3 3
16 BASHARAN GOOD TOOTH PASTE 9 8,480 69 28 3 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1
17 PREM FAIR TOOTH PASTE 8 14,500 85 10 5 3 3 4 4 4 4 0 0 2 2 2 2 1 1 0 0
18 YESURAJ FAIR TOOTH PASTE 8 9,500 70 26 4 0 0 3 3 4 4 4 3 0 0 2 2 3 3 3 3
19 SUNDARAMBAL FAIR UNBRANDED 8 5,000 56 40 4 3 3 4 4 4 4 4 4 2 2 2 2 2 1 1 1
20 RAJENDRAN POOR UNBRANDED 9 5,800 57 40 3 4 4 4 4 3 3 3 3 3 3 2 2 2 1 1 1
21 DURAIMANIKAM FAIR SHARP STICK 8 5,000 58 48 4 3 3 4 4 3 1 1 1 1 1 1 3 2 0 0 0
22 PRABU FAIR TOOTH PASTE 10 6,280 65 32 3 3 3 2 2 2 0 0 0 2 2 2 2 0 0 0 0
23 MAHALAKSMI POOR UNBRANDED 8 5,400 60 37 3 4 4 4 4 4 4 4 4 2 2 3 3 3 3 3 3
24 VASANTHA POOR UNBRANDED 9 4,200 58 39 3 3 3 3 3 3 4 4 4 1 1 1 1 2 2 2 2
25 ARUN KARTHI GOOD TOOTH PASTE 8 5,000 58 39 3 3 3 3 3 3 2 2 2 1 1 1 1 1 1 1 1
26 DHARMARAJ FAIR SHARP STICK 9 5,000 62 35 3 0 0 3 3 3 3 3 3 0 0 1 1 1 1 1 1
27 RANI POOR UNBRANDED 6 5,000 61 36 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
28 SUNDARARAJAN FAIR TOOTH PASTE 7 6,200 59 37 4 3 3 3 3 3 4 2 2 2 2 2 2 2 3 1 1
29 RAMESH POOR SHARP STICK 10 10,600 64 32 4 3 3 4 4 4 2 2 2 2 2 2 2 2 2 2 2
30 MEENA POOR UNBRANDED 11 8,500 57 40 3 4 4 4 4 4 1 1 1 2 2 2 2 2 0 0 0
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31 2 MARIMUTHU 30 MALE 20 5 PRIMARY COOLIE 5,000 5,5  5,5    Y Y Y Y Y Y Y Y
32 2 RAMAN 60 MALE 3 5 PRIMARY COOLIE 5,000 35,5  35,5    Y Y Y Y Y Y Y Y
33 2 CHANDRASEKAR 20 MALE 25 9 HIGH COOLIE 5,000     2,5  Y Y Y Y Y Y Y Y
34 2 SANTHANAMERY 40 FEMALE 5 3 PRIMARY SALES WOMAN 5,000     5,10  Y Y Y Y Y Y Y Y
35 2 MUTHUPANDI 14 MALE 4 8 MIDDLE STUDENT 0     2,5  Y Y Y Y Y Y Y Y
36 2 SUNDARARAJAN 55 MALE 5 NIL NIL COOLIE 5,000 20,5  20,5    Y Y Y Y Y Y N N
37 2 BAKIARAJ 33 MALE 10 10 HIGH BUS CON 7,500  3,5     Y Y Y Y Y N N N
38 2 VASUKI 44 FEMALE 25 NIL NIL COOLIE 4,000   30,10    Y Y Y Y Y N N N
39 2 MARIMUTHU 30 MALE 25 MA DEGREE LECTURER 12,000     5,5 5,10 Y Y Y Y Y N N N
40 2 GANGHIMATHI 50 FEMALE 65 NIL NIL HW 0   20,5    Y Y Y Y Y Y Y N
41 2 KARTHIK 29 MALE 20 10 HIGH CORPENDER 10,000    4,4  4,4 Y Y Y Y Y Y Y Y
42 2 SUGUMAR 31 MALE 6 4 PRIMARY COOLIE 6,000    12,5   Y Y Y Y Y Y Y Y
43 2 KASIAMMAL 50 FEMALE 20 NIL NIL COOLIE 3,500 25,10      Y Y Y Y Y Y Y Y
44 2 MARUTHAMBAL 50 FEMALE 5 NIL NIL COOLIE 3,000 10,10      Y Y Y Y Y Y Y Y
45 2 LAKSMI 47 FEMALE 20 10 HIGH COOLIE 3,500     5,10  Y Y Y Y Y Y Y Y
46 2 VIJAYA 40 FEMALE 12 5 PRIMARY COOLIE 4,000   10,5    Y Y Y Y Y Y Y Y
47 2 PRABU 29 MALE 20 10 HIGH VENDOR 5,000    3,6  7,6 Y Y Y Y Y Y Y Y
48 2 SARAN 15 MALE 5 9 HIGH STUDENT 0     2,10  Y Y Y Y Y Y Y Y
49 2 MAHAMUNY 37 MALE 25 10 HIGH H.SERVER 5,000   10,6    Y Y Y Y Y Y Y Y
50 2 KALYANASUNDRAM 24 MALE 28 BSC DEGREE TEACHER 7,500    5,20   Y Y Y Y Y N N Y
51 2 VIJAYALAKSMI 38 FEMALE 30 12 HIGER SECONDARY VENDOR 6,000   11,5    Y Y Y Y Y Y Y Y
52 2 CHANDRA 40 FEMALE 25 5 PRIMARY COOLIE 3,000     5,10  Y Y Y Y Y Y Y Y
53 2 BALASARSWATHY 35 FEMALE 23 9 HIGH HW 0     5,10  Y Y Y Y Y Y Y Y
54 2 SELVAM 33 MALE 9 10 HIGH MECHANIC 5,000    3,10 3,10  Y Y Y Y Y Y Y Y
55 2 PRAKASH 15 MALE 25 9 HIGH STUDENT 0    2,5 2,5  Y Y Y Y Y Y Y Y
56 2 MUTHUKANNU 50 FEMALE 25 NIL NIL COOLIE 4,500 25,5  25,5    Y Y Y Y Y Y Y Y
57 2 RUKMANI 55 FEMALE 25 NIL NIL COOLIE 4,000   15,5    Y Y Y Y Y Y Y Y
58 2 KULANTHIRAJ 52 MALE 10 6 MIDDLE CORPENDER 10,000    5,5  5,5 Y Y Y Y Y Y Y Y
59 2 THANGARAJ 46 MALE 60 10 HIGH COOLIE 5,000 25,10  25,10   20 30,10 N Y Y Y Y Y Y Y
60 2 ANJALAI 29 FEMALE 12 5 PRIMARY COOLIE 5,000     5,5  Y Y Y Y Y Y Y Y
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31 MARIMUTHU FAIR TOOTH PASTE 7 7,500 68 28 4 4 4 3 3 3 4 2 1 2 2 2 2 2 2 1 1
32 RAMAN POOR UNBRANDED 8 6,600 50 45 5 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2
33 CHANDRASEKAR FAIR TOOTH PASTE 8 3,300 69 27 4 3 3 3 3 3 3 3 3 2 2 2 2 2 2 2 2
34 SANTHANAMERY FAIR UNBRANDED 10 3,000 68 28 4 4 4 4 4 4 4 4 4 2 2 2 2 2 2 2 2
35 MUTHUPANDI FAIR TOOTH PASTE 7 6,500 58 40 2 3 3 4 4 4 4 4 4 2 2 3 3 3 3 3 3
36 SUNDARARAJAN POOR SHARP STICK 10 5,000 50 48 2 3 3 3 3 3 4 0 0 2 2 2 2 2 2 0 0
37 BAKIARAJ FAIR TOOTH PASTE 9 7,000 58 40 2 3 3 4 2 2 0 0 0 1 1 1 1 1 0 0 0
38 VASUKI FAIR UNBRANDED 6 10,800 70 28 2 3 3 4 3 3 0 0 0 2 2 2 2 2 0 0 0
39 MARIMUTHU GOOD TOOTH PASTE 7 5,000 51 45 4 3 3 4 4 4 0 0 0 3 3 3 3 3 0 0 0
40 GANGHIMATHI POOR UNBRANDED 8 5,600 51 44 5 3 3 3 4 4 4 4 1 2 2 2 3 3 3 3 1
41 KARTHIK POOR UNBRANDED 8 3,000 50 48 2 3 3 4 4 4 4 4 4 2 2 2 2 2 2 2 2
42 SUGUMAR POOR UNBRANDED 8 5,000 63 34 3 4 4 4 4 4 4 4 4 3 3 3 3 3 3 3 3
43 KASIAMMAL POOR SHARP STICK 10 11,600 42 57 1 4 4 4 4 4 4 4 4 2 2 3 3 3 3 3 3
44 MARUTHAMBAL POOR SHARP STICK 8 6,400 57 40 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
45 LAKSMI POOR UNBRANDED 8 3,200 66 31 3 3 3 3 3 3 3 3 3 1 1 2 2 2 2 1 1
46 VIJAYA POOR UNBRANDED 11 13,500 50 48 2 3 3 3 3 3 1 1 3 1 1 1 1 1 1 1 1
47 PRABU FAIR TOOTH PASTE 9 3,500 52 45 3 3 3 3 3 1 1 1 1 1 1 2 2 1 1 1 1
48 SARAN FAIR TOOTH PASTE 8 3,800 69 28 3 3 3 3 3 3 2 1 1 1 1 2 2 2 1 1 1
49 MAHAMUNY FAIR TOOTH PASTE 8 5,600 66 32 2 3 3 4 4 4 4 4 4 1 1 2 2 2 3 1 2
50 KALYANASUNDRAM GOOD TOOTH PASTE 11 8,550 60 38 2 3 3 3 3 3 1 1 1 2 2 2 2 2 1 1 1
51 VIJAYALAKSMI FAIR TOOTH PASTE 9 6,500 58 40 2 3 3 3 3 4 0 0 1 2 2 2 2 2 1 0 1
52 CHANDRA FAIR SHARP STICK 6 5,800 65 30 5 3 3 3 3 2 4 4 4 2 2 2 2 2 3 3 3
53 BALASARSWATHY POOR UNBRANDED 7 6,400 57 40 3 4 4 4 4 4 4 4 4 3 3 3 3 3 0 0 3
54 SELVAM POOR TOOTH PASTE 10 6,600 71 24 5 3 3 3 3 3 2 2 2 2 2 2 2 2 1 1 1
55 PRAKASH POOR UNBRANDED 8 3,300 69 27 4 1 1 3 4 3 1 2 1 1 1 1 1 1 1 1 1
56 MUTHUKANNU POOR UNBRANDED 10 7,600 76 20 4 4 4 4 4 2 1 2 1 2 2 2 2 1 1 1 1
57 RUKMANI POOR UNBRANDED 6 12,000 58 40 2 4 4 3 4 3 4 4 3 2 2 2 2 2 3 2 2
58 KULANTHIRAJ POOR UNBRANDED 7 10,800 70 28 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1
59 THANGARAJ POOR UNBRANDED 9 7,200 65 31 4 3 3 4 4 4 2 2 2 2 2 2 2 2 2 2 2
60 ANJALAI POOR UNBRANDED 10 7,800 68 28 4 4 4 3 3 3 2 1 1 2 2 2 2 2 1 1 1

QUESTIONNAIRE FOR THE STUDY ON  
ORAL SUBMUCOUS FIBROSIS 
   
NAME OF THE PATIENT   :              OP/IP NO :  
AGE    :        SEX  :  
ADDRESS   :  
 
 
DISTANCE FROM THE MEDICAL FACILITY :  
EDUCATION   :  
OCCUPATION     :    
MONTHLY INCOME :  
 
HABITS DURATION  QUANTITY FREQUENCY 
TOBACCO ALONE    
TOBACCO WITH BETEL 
NUT 
   
BETEL LEAF WITH BETAL  
NUT WITH LIME 
   
PAN MASALA 
FABRICATED BETEL NUT    
ALCOHOL    
SMOKING    
SPICY FOOD    
   
    
CLINICAL SYMPTOMS YES NO  
BURNING SENSATION ON 
TAKING FOOD  
  
DRYNESS OF MOUTH    
                                         
 
CLINICAL SIGNS YES NO             
TRISMUS    
BLANCHING    
FIBROUS BAND    
ANKYLOGLOSSIA   
STOMATITIS    
SOFT PALATE INVOLVEMENT    
   
 
ORAL HYGIENE:                POOR                     FAIR                  GOOD 
 
MATERIAL USED FOR BRUSHING: TOOTH PASTE/ SHARP 
STICKS/UNBRANDED POWDER 
 
LAB INVESTIGATIONS  
Hb %   : 
TC                 :                     ,  DC- P    %,  L     %, M       %, E      %.        
 PRE TREATMENT - SYMPTOMS 
SCORE    
0 1 2 3 4 
BURNING SENSATION ON TAKING 
FOOD   
          
DRYNESS OF MOUTH             
   
  PRE TREATMENT - SIGNS 
SCORE     
0 1 2 3 4 
TRISMUS             
BLANCHING             
FIBROUS BAND             
ANKYLOGLOSSIA           
STOMATITIS             
SOFT PALATE INVOLVEMENT             
     
 
 POST TREATMENT - SYMPTOMS 
SCORE    
0 1 2 3 4 
BURNING SENSATION ON TAKING 
FOOD   
          
DRYNESS OF MOUTH             
   
   POST TREATMENT - SIGNS 
SCORE    
0 1 2 3 4 
TRISMUS             
BLANCHING             
FIBROUS BAND             
ANKYLOGLOSSIA           
STOMATITIS             
SOFT PALATE INVOLVEMENT             
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1. INTRODUCTION Oral sub mucous fibrosis is a precancerous lesion, predominant condition seen
in South Asian ethnic group ,more in India .No age or sex predilection has been found. OSMF is
primarily a cell mediated immune reaction to areca nut chewing and betel quid. It is prevalent in people
belonging to poor socioeconomic status associated with nutritional deficiency. In 1953 S.G.Joshi
termed this condition as Oral sub mucous fibrosis. And latter it was described by Pindborg and Sirsat
in (1966). 1 In simple words Oral sub mucous fibrosis is a chronic progressive crippling fibrotic but
preventable disease. Manifestations are dryness and burning sensation in the mouth, blanching of
oral...
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